Paratek Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Paratek Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 25% to $150,788,000. Profit margin reached -42%. Total operating expenses were $173,941,000.
Profit Margin
| 2013 | 1.74M | -27.44M | -1571.04% |
|---|---|---|---|
| 2014 | 4.34M | -17.83M | -410.76% |
| 2015 | 0 | -70.86M | |
| 2016 | 29K | -111.63M | -384951.72% |
| 2017 | 12.61M | -89.06M | -706% |
| 2018 | 17.11M | -112.35M | -656.4% |
| 2019 | 16.54M | -128.79M | -778.47% |
| 2020 | 43.51M | -116.25M | -267.16% |
| 2021 | 120.95M | -59.08M | -48.85% |
| 2022 | 150.78M | -63.56M | -42.16% |
PRTK Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 150.78M | 120.95M | 43.51M | 16.54M | 17.11M | 12.61M | 29K | 0 | 4.34M | 1.74M |
Cost of revenue | 23.05M | 21.53M | 8.65M | 3.48M | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 127.73M | 99.41M | 34.86M | 13.06M | 17.11M | 12.61M | 29K | 0 | 4.34M | 1.74M |
Operating exp. | ||||||||||
Research and development | 37.82M | 30.35M | 23.92M | 39.55M | 57.50M | 60.07M | 83.46M | 50.76M | 5.01M | 6.90M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.82M |
Total operating expenses | 173.94M | 140.54M | 110.37M | 128.68M | 121.16M | 97.03M | 109.86M | 70.75M | 10.86M | 26.15M |
Operating income | -46.20M | -41.13M | -75.50M | -115.62M | -104.08M | -84.58M | -109.48M | -70.05M | -7.79M | -27.37M |
Other income (expenses), net | -17.3M | -17.35M | -21.03M | -12.86M | -80K | -3.73M | 349K | -807K | -10.03M | -2.96M |
Income before tax | -63.50M | -58.48M | -96.54M | -128.48M | -111.85M | -88.31M | -111.63M | -70.86M | -17.83M | -27.44M |
Income tax expense | 57K | 600K | 19.71M | 301K | 502K | 753K | 3.22M | 19K | 419K | 2.94M |
Net income | -63.56M | -59.08M | -116.25M | -128.79M | -112.35M | -89.06M | -111.63M | -70.86M | -17.83M | -27.44M |
Earnings per share | ||||||||||
Basic EPS | -1.17 | -1.22 | -2.63 | -3.93 | -3.57 | -3.32 | -5.51 | -4.29 | -7.05 | -17.54 |
Diluted EPS | -1.17 | -1.22 | -2.63 | -3.93 | -3.57 | -3.32 | -5.51 | -4.29 | -7.05 | -17.54 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |